PI3K-Akt signaling pathway, cell cycle and ubiquitin mediated proteolysis were the top three enriched pathways that might serve as important pathways for Cynarine in the treatment of NAFLD (Fig. 4D). This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.